Vall d'Hebron Institut d'Oncologia (VHIO)

Barcelona 08035

1 studies enrolling now · 3 studies all time

What they study most

Advanced Solid Tumor, Advanced Urothelial Carcinoma, Bladder Cancer, Carcinoma, Colorectal Cancer Metastatic, FGFR3 Gene Alteration, FGFR3 Gene Mutation, Locally Advanced Urothelial Carcinoma, Metastatic Colorectal Cancer, Metastatic Head-and-neck Squamous-cell Carcinoma, Metastatic Urothelial Carcinoma, Non-muscle-invasive Bladder Cancer

Studies at this site

• A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma — Recruiting now
• Safety and Preliminary Anti-Tumor Activity of TYRA-300 in Advanced Urothelial Carcinoma and Other Solid Tumors With FGFR3 Gene Alterations — Running, not enrolling
• Sym004 Versus Futuximab or Modotuximab in Patients With mCRC — Stopped early